MUHC Innovation Hub Fixes Medtech's Testing Bottleneck

The McGill University Health Centre (MUHC) and its research arm The Institute officially opened the IMPACT Centre on Tuesday. The hub targets a specific bottleneck that has held back medical technology adoption in Canada: the gap between a working prototype and a validated product in a live clinical setting.

For early-stage medtech companies, that gap is often fatal. A lab-tested algorithm for infection monitoring or a scheduling platform for nurses can look promising on paper. Without a real hospital environment to prove it works, the product stalls. The IMPACT Centre provides that environment, giving partner startups access to the MUHC’s physicians, nurses, and patient populations.

The Clinical Validation Problem the IMPACT Centre Solves

Why Medtech Startups Struggle in Canada

Canada has strong research output in medtech, the translation to clinical practice is slow. Dr. Alan Forster, The Institute’s director of innovation, performance, and quality, told BetaKit that the initiative targets several pain points companies face. “They need clinical environments to test their products, or first adopters,” Forster said. “We want to greatly accelerate that.”

Without that acceleration, promising tools sit on the shelf. Hospital procurement committees are risk-averse. A product tested at a top research hospital like the MUHC carries more weight than one tested in a simulation. The credibility alone is a significant asset for startups.

How the Hub Bridges the Gap

The IMPACT Centre functions as a structured bridge between the lab and the ward. Dr. Rhian Touyz, executive director and chief scientific officer at The Institute, described the advantage in Tuesday’s announcement.

“A discovery made in one of our laboratories doesn’t have to travel very far before it begins changing how we care for our patients.”

Key insight: The hub’s value is not just physical space. It is the ability to test within an operational hospital where real constraints – staff workflows, patient volumes, regulatory requirements – apply. That is the environment that uncovers flaws a lab test would miss.

Case Studies from the Launch Day

Several companies demonstrated their technology at the launch event. The two examples below illustrate the range of problems the hub will tackle.

Lumenix and the Infection Prevention Challenge

Ottawa-based Lumenix developed AIMS, an AI-powered monitoring system that uses always-on surveillance cameras to detect when someone approaches a patient without sanitizing their hands. The system issues a warning signal to staff and families while keeping individuals’ identities anonymous. Hospital-acquired infections remain a costly and dangerous problem. AIMS directly targets that risk.

Airudi and the Nurse Staffing Puzzle

Montréal-based Airudi builds AI-infused software for multiple sectors. Its ENACT platform, developed in collaboration with the MUHC, optimizes nurse staffing and shift assignments. Nurse shortages are chronic. Better scheduling can improve both patient outcomes and staff retention. Marc Plamondon, Airudi vice-president of business development, described the IMPACT Centre as a “junction between innovation and operation.” He added: “It’s making sure we can work together on the ground and test our solution.”